Latest from ESMO congresses
The ESMO Daily Reporter is the official ESMO newspaper providing live reporting, highlights, critical insights on data presented at ESMO congresses, and expert opinions on controversial topics.
Newsroom
Read the latest news and updates from ESMO and the oncology community
Resources for Media
For media interested in reporting on cancer issues, check for the latest press releases and press briefings, abstract announcements, embargo policies, meeting information and tailored resources.
The unique needs of LGBTQ cancer patients are still poorly understood
An in-depth reflection on gaps in medical knowledge and research with Emmanouil Saloustros and Liz Margolies
Society Updates
European Lung Cancer Congress 2022 to Be a Virtual-Only Event
In light of the challenging situation in Prague due to the ongoing arrival of refugees from Ukraine
Against Any War
ESMO expresses profound sadness about the unfolding tragedy in Ukraine and the suffering of people
Covid and Cancer Portal
Latest news and resources to tackle the pandemic era
Oncology News
Short-Term Radiotherapy with Preoperative Chemotherapy Followed by Surgery is Efficacious with Acceptable Toxicity in Locally Advanced Rectal Cancer
Findings from the randomised, phase III STELLAR study
FDA Approves Olaparib for Adjuvant Treatment of High-Risk Early Breast Cancer
Patients must be selected for therapy based on an FDA-approved companion diagnostic for olaparib
EMA Adopts a Revised Opinion for Enfortumab Vedotin After Further Safety Information Emerged During the Decision-Making Process
It is intended for the treatment of adult patients with urothelial cancer